Balaxi Pharmaceuticals’ arm completes acquisition of 99% stake in BHES

08 Nov 2021 Evaluate

Balaxi Pharmaceuticals’ wholly owned subsidiary -- Balaxi Global DMCC, Dubai (BGD), has completed acquisition of 99% shares of Balaxi Healthcare El Salvador, S.A DE C.V, El Salvador, Central America (BHES), which has consequently become the step-down subsidiary of Balaxi Pharmaceuticals.

Balaxi Pharmaceuticals operates as an investment company in India.

Peers
Company Name CMP
Redington 273.35
Adani Enterprises 2154.00
Amrapali Industries 14.62
Rashi Peripheral 365.25
PDS 349.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×